In a report released today, Raj Jilka from Jefferies maintained a Buy rating on Sanofi (SNYNF – Research Report), with a price target of €120.00. The company’s shares opened today at $98.93.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sanofi estimates that the annual cost for a typical patient will be around $280,000 per year before discounts or rebates, in line with other drugs used to treat rare, chronic diseases.

Sanofi said this morning that its pipeline includes 12 potential blockbuster drugs that could generate more than €10 billion ($11 billion) in annual sales by the end of the decade, a sharp ...

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sanofi with a $126.14 average price target, which is a 14.33% upside from current levels. In a report ...

MATTHEW LAMBWELL: Katie Boulter's arc of redemption sent Great Britain into the finals of the Billie Jean King Cup. In a winner-take all tie against hosts Netherlands to decide this group stage ...

Jonah Platt, the son of film producer Marc Platt, has unleashed an explosive tirade against controversial Snow White actress Rachel Zegler. Zegler, 23, took to X, formerly known as Twitter, in ...

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13,908.88 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...